GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Enterprise Value

StemRIM (TSE:4599) Enterprise Value : 円19,338 Mil (As of May. 22, 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, StemRIM's Enterprise Value is 円19,338 Mil. StemRIM's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was 円181 Mil. Therefore, StemRIM's EV-to-EBIT ratio for today is 106.68.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, StemRIM's Enterprise Value is 円19,338 Mil. StemRIM's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was 円181 Mil. Therefore, StemRIM's EV-to-EBITDA ratio for today is 106.68.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, StemRIM's Enterprise Value is 円19,338 Mil. StemRIM's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was 円2,350 Mil. Therefore, StemRIM's EV-to-Revenue ratio for today is 8.23.


StemRIM Enterprise Value Historical Data

The historical data trend for StemRIM's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Enterprise Value Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Enterprise Value
Get a 7-Day Free Trial - 35,901.78 28,853.12 41,021.50 46,155.33

StemRIM Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46,907.84 68,011.88 46,155.33 29,815.71 24,562.93

Competitive Comparison of StemRIM's Enterprise Value

For the Biotechnology subindustry, StemRIM's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemRIM's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Enterprise Value distribution charts can be found below:

* The bar in red indicates where StemRIM's Enterprise Value falls into.



StemRIM Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

StemRIM's Enterprise Value for the fiscal year that ended in Jul. 2023 is calculated as

StemRIM's Enterprise Value for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM  (TSE:4599) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

StemRIM's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=19337.991/181.279
=106.68

StemRIM's current Enterprise Value is 円19,338 Mil.
StemRIM's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円181 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

StemRIM's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=19337.991/181.279
=106.68

StemRIM's current Enterprise Value is 円19,338 Mil.
StemRIM's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円181 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

StemRIM's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=19337.991/2350
=8.23

StemRIM's current Enterprise Value is 円19,338 Mil.
StemRIM's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,350 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM Enterprise Value Related Terms

Thank you for viewing the detailed overview of StemRIM's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines